Impact of the FDA Premarket Guidance of Management of Cybersecurity in Medical Devices
It has been one year since the FDA released the latest Guidance Document pertaining to managing Cybersecurity in Medical Devices. What impact is this guidance having on medical device manufacturers and how are they handling pre-market submissions? In this webinar, medical device cybersecurity experts at Emergo by UL will examine how this guidance is affecting the medical device market. Here's what you will learn:
- What are the highlights of the FDA Premarket Guidance of Management of Cybersecurity in Medical Devices?
- How has it impacted the Premarket Submission Process?
- What has been the impact been on manufacturers?
- How can manufacturers best prepare to meet the requirements?
ABOUT THE PRESENTER
Chris Beeman is the Business Development Manager for the Digital Health team. Chris works with manufacturers, regulatory stakeholders, and health delivery organizations to develop solutions to address and mitigate the cybersecurity risk throughout the product development lifecycle. He holds a bachelor's in Business Administration from the University of Richmond.
This webinar was recorded on October 17, 2019.
Questions? Request more information from our specialists
CONTACT USRelated
-
Transitioning to Medical Device Single Audit Program (MDSAP) Compliance
As the first year of its operational phase ends, the Medical Device Single Audit Program (MDSAP) is finally gaining traction among medical device m
read more -
Wearables vs. Regulated Medical Devices under the US FDA
One of the biggest challenges for companies in the general wellness space is understanding how and when their technology might encounter FDA regula
read more